Posted On: 10/06/2014 7:17:39 PM
Post# of 67
$PGNX after hours Pr. $4.92
Progenics Receives $40 Million Milestone Following FDA Approval
of RELISTOR for OIC Patients With Chronic Non-Cancer Pain
Website
10-Q 8/8/14
Summary
Shares Outstanding: 69.56M
Float: 54.47M
Progenics Receives $40 Million Milestone Following FDA Approval
of RELISTOR for OIC Patients With Chronic Non-Cancer Pain
Website
10-Q 8/8/14
Summary
Shares Outstanding: 69.56M
Float: 54.47M
(0)
(0)Scroll down for more posts ▼
